BMI indicates body mass index; CI, confidence interval; CNP, C-type natriuretic peptide; E, mitral peak velocity of early filling; and HR, hazard ratio. HR for subjects with values in the highest ...

Peptides have emerged as a focal point in molecular and biological research, providing a promising avenue for understanding ...

Objectives To compare the stability of brain natriuretic peptide (BNP) to that of N-terminal atrial natriuretic peptide (NT-ANP) in whole blood and plasma stored under different conditions. To compare ...

CSW is a transient phenomenon in which kidneys are unable to conserve sodium. CSW leads to serum hyponatremia and hypovolemia as a result of SAH or other intracranial disease (Harrigan, 2001).

Natriuretic peptides, especially B-type natriuretic peptide (BNP), have primarily been regarded as biomarkers in heart failure (HF). However, they are also possible therapeutic agents due to their ...

Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Testing for natriuretic peptide markers, such as B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP), has ...

The following is a summary of “Impact of sodium-glucose cotransporter 2 inhibitors on catheter ablation for atrial fibrillation in heart failure patients without type-2 diabetes,” published in the ...

However, anaemia sometimes remains undetected because the superficial cardiac function does not precisely reflect the adverse impact of anaemia. Plasma B-type natriuretic peptide (BNP) could be ...

Carperitide is under clinical development by Daiichi Sankyo and currently in Phase II for Contrast Induced Nephropathy.

A recent groundbreaking study found that NT-proBNP levels are associated with an increased risk of atrial fibrillation in older adults, as per results that were published in the journal Heart.

RVD was identified in 461 (57%) patients. Correlates of RVD included older age, higher heart rate, atrial fibrillation/flutter, greater left ventricle wall thickness, higher N‐terminal pro‐B‐type ...